本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ventyx Biosciences, Inc.

3.56
-0.3000-7.77%
盤後3.50-0.0600-1.69%18:55 EDT
成交量:147.40萬
成交額:533.27萬
市值:2.54億
市盈率:-2.12
高:3.88
開:3.86
低:3.48
收:3.86
52周最高:4.05
52周最低:0.7830
股本:7,130.85萬
流通股本:5,355.59萬
量比:0.89
換手率:2.75%
股息:- -
股息率:- -
每股收益(TTM):-1.6773
每股收益(LYR):-1.9732
淨資產收益率:-48.56%
總資產收益率:-30.23%
市淨率:1.21
市盈率(LYR):-1.80

資料載入中...

2023/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/26

重要事件披露

Form 8-K - Current report
2023/07/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/20

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/11

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities